|
⚲
|
| Keyboard |
| Ladone Mary Kay
✚
|
|
|---|---|
| CIK # | 0001760737 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001760737] | |
| 4 | [0001760737] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ladone Mary Kay | |
| Inogen Inc | |
| Bioventus Inc | |
| Novanta Inc | |
| Kestra Medical Technologies Ltd | |
| Hill-Rom Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novanta Inc NOVT
Common Stock
|
2026-01-02 | Option exercise | 1,325 | ||
|
Novanta Inc NOVT
Restricted Stock Units · derivative
|
2026-01-02 | Grant | 1,799 | $0.00 | |
|
Novanta Inc NOVT
Restricted Stock Units · derivative
|
2026-01-02 | Option exercise | 1,325 | ||
|
Novanta Inc NOVT
Common Stock
|
2025-07-11 | Option exercise | 572 | ||
|
Novanta Inc NOVT
Restricted Stock Units · derivative
|
2025-07-11 | Option exercise | 572 | ||
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2025-06-03 | Grant | 32,282 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2025-06-02 | Option exercise | 26,493 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2025-06-02 | Option exercise | 26,493 | $0.00 | |
|
Inogen Inc INGN
Common Stock
|
2025-05-14 | Grant | 30,612 | $0.00 | |
|
Novanta Inc NOVT
Restricted Stock Units · derivative
|
2025-01-02 | Grant | 1,325 | $0.00 | |
|
Novanta Inc NOVT
Restricted Stock Units · derivative
|
2024-07-11 | Grant | 572 | ||
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2024-06-16 | Option exercise | 1,814 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2024-06-16 | Option exercise | 1,814 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2024-06-11 | Grant | 26,493 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2024-06-07 | Option exercise | 30,400 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2024-06-07 | Option exercise | 30,400 | $0.00 | |
|
Inogen Inc INGN
Common Stock
|
2024-06-05 | Grant | 21,871 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2023-06-16 | Option exercise | 1,813 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2023-06-16 | Option exercise | 1,813 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2023-06-07 | Grant | 30,400 | $0.00 | |
| showing 20 of 109 most recent transactions | |||||